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Background: Transfusion-transmissible infections (TTIs) pose a major health risk in Cameroon given the high
prevalence of such pathogens and increased demands for blood donations in the local communities. This study
aims at establishing the prevalence of commonly encountered TTIs among blood donors and transfusion-related
complications among recipients in an urban center of Cameroon.
Methods: A total of 477 blood donors and 83 blood recipients were recruited by consecutive sampling at the
Laquintinie Hospital in Douala (LHD), Cameroon. Serum samples from blood donors were tested by quantitative
enzyme-linked immunosorbent assays (ELISA) and/or using various Rapid diagnostic test (RDT) for presence of
Hepatits B (HBV) viral antigens, and antibodies to human immunodeficiency (HIV-1/2), Hepatits B (HCV) and
Treponema pallidum. Recipient’s medical records were also analyzed for possible transfusion-associated
complications.
Results: The male/female sex ratio of the blood donors was 4/1 with a mean age of 30.2 (Sd = 8.3) years. Of all
blood donors, 64/467 (13.7%) were infected by at least one of the four TTIs. Infected volunteer donors represented
8.3% while infected family donors comprised 14.3% of the donor population. The prevalence of HCV, HIV, HBV and
T. pallidum were 1.3%, 1.8%, 3.5%, and 8.1%, respectively. More than half of the blood recipients were female
(78.3%) and the mean age was 20.6 (SD = 16.1) years. The causes of severe anemia indicative of transfusion in
recipients varied with wards (postpartum hemorrhage, caesarean section, uterine or cervical lacerations, abortions,
urinary tract infections, severe malaria, vaso-occlusive attacks, wounds and gastrointestinal bleeding). The most
frequent complications were chills and hematuria, which represented 46.1% of all observed complications. Other
complications such as nausea, vomiting, jaundice, sudden diarrhea, anxiety, tachycardia, or hyperthermia were also
found in recipients. Three cases of deaths occurred during the study, including a girl of less than one year.
Conclusion: This study confirms the presence of blood-borne infectious diseases in blood donors at the LHD,
identifying T. pallidum as the greatest threat to blood safety in the region, and hematuria as the most common
immunological complications in blood recipients.
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Blood transfusion therapy is used among patients with se-
vere anemia due to various medical, surgical or obstetric
conditions, and in patients undergoing transplantation of
an organ. Blood transfusion is beneficial and safe for the
recipient when it is performed in strict compliance with
immunological and hygienic standards, and following a
strict screening of donors. In Cameroon, the current blood
safety guidelines necessitate blood banks to routinely per-
form serological testing for human immunodeficiency
virus (HIV), hepatitis B virus (HBV), hepatitis C virus
(HCV), and Treponema pallidum (T. pallidum). These
guidelines progressively followed the exponential rise in
blood donors from 75,000 in 1992 to 130,000 in 2002 [1],
however, necessitate regular monitoring and adaptation to
frequently changing epidemiological and demographic pa-
rameters that include urbanization, migration flows, and
increased demand for blood transfusion in the country.
Although blood safety has greatly improved over the past
15 years, TTIs still represent a major public health pro-
blem in Cameroon given the high prevalence of HIV
infections, hepatitis, malaria, and several sexually trans-
missible diseases (STD) [2,3]. Data recorded in 2006 show
that 26,079 units of blood were collected in health faci-
lities in Cameroon with over 2,477 infected cases, thus a
TTIs prevalence of 9.5% among blood donors. Of these in-
fectious risks, viral infections (HIV, HBV and HCV) are
the most feared by patients and prescribers [4-7]. In
Cameroon, screening for hepatitis B and C virus was not
part of routine tests performed in blood donors until the
year 2005. The reduction of the residual risk of contami-
nation is currently based on a strict selection of donors
and the introduction of new tests such as genomic testing
for HIV, HCV and HBV [6,8]. A study conducted among
blood donors at the Yaoundé Central Hospital (YCH) re-
vealed that the risk of TTI from patients with residual in-
fections remains high (9.8%) in Cameroon [9]. Bacterial
contamination remains a major risk of infection during
blood transfusions. Endotoxic shock caused by massive,
usually Gram-negative, bacterial contamination is rare but
represent a very serious outcome that includes sudden
death [10]. Bacterial infections including T. pallidum have
been reported in Cameroon, and are common in many
other countries [11-14].
Despite the considerable efforts in limiting infection-
related complications of blood transfusion, the risk of
adverse pleiotropic reactions to transfused blood re-
mains present. Among these transfusion-related compli-
cations, immunological reactions and hypervolemia are
the most common [10,15]. Some reactions happen as
soon as the transfusion is started, while others take se-
veral days or months to develop. Evaluation of transfu-
sion complications in blood recipients is necessary for a
full understanding of its etiology, and must involve apermanent and systematic collection and reporting of
cases at blood transfusion centers. In 2003, a law on the
rapid and proper cases management at local health faci-
lities free of charge has been adopted in Cameroon to
complete institutional reforms on blood safety [16].
Till date, very few studies have been carried out in
Cameroon to assess the complications due to transfusion
and most of them concern the prevalence of infections
in blood donors [9,16,17]. This study aimed to study the
prevalence of common TTIs among blood donors and
to analyze the possible complications due to blood trans-
fusion among recipients at the Laquintinie Hospital in
Douala (LHD), a major blood transfusion center in the
coastal region of Cameroon.
Methods
Study population and design study
We conducted a four-month transversal descriptive survey
starting from August 2012 at LHD. We included indivi-
duals attending the blood transfusion center (BTC) for
voluntary or family blood donation, and hospitalized pa-
tients in the Pediatric, Emergency, and Gyneco-obstetrical
wards who recently underwent blood transfusion. Before
enrollment, subjects or patients, or parents, or legal
guardians were informed on the purpose and process of
the investigation (goals, methodology, study constraints,
data confidentiality, and rights to opt out from the study),
and a written informed consent was obtained from all
participants. Standard questionnaires and data collec-
tion sheets were used to collect anthropometric, socio-
demographic, and clinical and biological data. This study
was conducted in accordance with ethics directives related
to research on humans in Cameroon. Ethical clearance
was obtained from the LHD institutional review board,
whereas administrative clearance was obtained from the
Regional Delegation of Public Health for the Littoral
Region.
Detection of viral and bacterial infections
For each donor, 10 ml of whole blood were collected in
a dry tube. After centrifugation at 3000 rpm for 5 min,
serum was collected for the detection of viral and bac-
terial infections as depicted in Figure 1. A rapid diag-
nostic test (RDT) (Alere Determine™ HIV-1/2) was used
for the qualitative detection of anti-HIV-1/2 antibodies,
whereas an enzyme-linked immunosorbent assay
(ELISA Genscreen™ ULTRA HIV Ag-Ab) was employed
to detect the viral antigens in the plasma of donors. For
HBV, two tests were also used; a RDT-based assay (One
Step HBsAg Rapid Test) for the qualitative detection of
HBV surface antigen (HBsAg), and an ELISA test
(HBsAg Biorex®) for quanlitative detection of HBsAg.
An ELISA test (Biorex 4th Generation® Anti-HCV) was
also used for the detection of anti-HCV antibodies in
Figure 1 Viral and bacterial infections testing strategies and algorithms. A, HIV and HBV diagnostic; B, HCV diagnostic; C, T. Pallidum diagnostic.
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(TPHA) test (Biolabo®) was used for the qualitative
and semi-quantitative detection of anti-T. pallidum
antibodies.Blood group determination, cross matching and
transfusion-related complications
Samples were typed for ABO blood groups, using the
"Beth Vincent" and Simonin-Michon methods. Blood
unit samples were also cross-matched to confirm that
they matched the blood type of the recipient. Transfu-
sion reactions were collected from recipient patients’
medical records.Statistical analyzes of data
Data were presented as either grouped frequency tables,
or as means ± Standard Deviations (SDs) for normally
distributed numerical variables. Chi-square test or
Fisher’exact test were used for comparing proportions.
Numerical values were compared using the U-test of
Wilcoxon-Mann–Whitney. All statistical analysis were
done using the Excel and Stata software package
(version 11 SE). Only p-values <0.05 were considered
significant in these analyses.Results
Blood donors’ population study
Characteristics of blood donors
We included 477 blood donors in the study, 50 (10.5%)
were volunteer donors whereas 427 (89.5%) were family
donors. Overall, the male/female sex ratio amongst all do-
nors was 4/1 (381/96). The demographic characteristics of
both the volunteer and family donors are presented in
Table 1. We observed a significantly higher mean age of
the volunteer donors compared to that of the family do-
nors (p =0.0017). No difference was observed for all other
identified characteristics of the participants. Blood donors
were more frequent in the 23–27 years age group, and de-
creased thereafter (Figure 2). The majority of donors of
age < 32 years were family members of the recipients,
whereas volunteer donors dominated the >32 years age
groups.
Most of donors (60.3%) had received secondary-school
education, 31.2% attended university studies, and 6.6%
had completed primary school. This distribution is sig-
nificantly different (p <10-4) between the two donors’
groups. In volunteer donors, 81.8% attended university
studies and 18.2% had received secondary-school educa-
tion. 64.0% of family donors had received secondary-
school education, 26.80% attended university studies and
7.2% had completed primary school.
Table 1 Sex, age, anthropometric and clinical characteristics of blood donors
Volunteer donors Family donors
Male Female Total Male Female Total Total p
(N = 37) (N = 13) (N = 50) (N = 344) (N = 83) (N = 427) (N = 477)
Age (SD), years 37.7 (9.6) 27.8 (5.2) 32.9 (9.2) 29.4 (7.9) 31.6 (8.7) 29.9 (8.2) 30,2 (8.3) 0.017
Weight (SD), Kg 77.6 (12.4) 66.9 (5.9) 74.8 (11.9) 75.5 (11.6) 70.3 (13.3) 74.5 (12.1) 74.5 (12.1) 0.94
Body mass index (SD), Kg/m2 25.5 (3.5) 26.1 (2.7) 25.7 (3.3) 24.9 (3.7) 26.3 (5.2) 25.3 (4.0) 25.3 (3.9) 0.11
Systolic blood pressure (SD), mmHg 131.2 (14.5) 113.1 (11.4) 126.4 (15.8) 129.9 (16.2) 120.2 (15.2) 128.0 (16.4) 127.8 (16.3) 0.47
Diastolic blood pressure (SD), mmHg 76.8 (9.8) 75.0 (8.8) 76.3 (9.5) 77.0 (11.2) 77.0 (10.6) 77.0 (11.0) 76.9 (10.9) 0.87
Pools (SD), bpm 76.6 (88.2) 78.7 (4.2) 77.2 (7.4) 77.3 (12.7) 83.1 (11.7) 78.4 (12.7) 78.3 (12.3) 0.62
Data are mean (SD) of various parameters according to donors' groups and gender; Variables were compared by Cross Kwalis test (continuous variables) and p < 0.05
was significant.
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whereas 25.6%, 18.7% and 3.5% belong respectively to
the A, B and AB blood groups. About 63% of these do-
nors were Rhesus positive.
Data on transfusion history were collected from 209
(209/427) family donors and 9 (9/50) volunteer donors.
Among these, 1.4% of family donors had previously re-
ceived a transfusion compared to 11.1% of the volunteer
donors. 66% of the volunteer donors had previously
donated blood compare to 48.3% of the family donors
(p = 0.03).
Seroprevalence of TTIs among blood donors
Eight donors (1.77%) were positive for anti-HIV anti-
bodies and were all family donors (Table 2). Out of 461
donors tested for HBsAg, 16 (3.5%) were positive, the
majority (93.7%) being family donors. Six donors (1.3%)
were positive for anti-HCV antibodies and 35 (8.1%) for
anti-T. pallidum antibodies. Among blood donors with
at least one infection, most of them (85.9%) were males.
Among the donors, only one had a double infectionFigure 2 Distribution of blood donors’ groups according to age class(HCV and T. pallidum). None of the infected donors
had previously received blood transfusion. No rcorrela-
tion was found between the presence of TTIs and other
transmission risk factors such as body piercing, tattoo,
sexual promiscuity, prostitution, drug abuse, or blood-
related accidents.
Blood recipients’ population study
Characteristics of blood recipients
The frequency and proportion of blood recipients accord-
ing to the ward, sex, hemoglobin concentration and mean
duration of transfusion are shown in Table 3. A total of 83
transfused patients agreed to participate in the study.
More than half of those who received transfusion were fe-
male with a female/male sex ratio of 3.6/1. The mean age
of recipients was 20.57 (range 0–86 years, SD = 16.09)
years, with two notable high frequency age groups:
1–4 years olds and 26–30 years olds (Figure 3). The mean
duration of transfusion was higher in the Pediatric ward
than in the Gyneco-obstetrical ward, consistent with the
guidelines for transfusion in children. The number ofes.
Table 2 Seroprevalence of infections risk in blood donation
Volunteer donors Family donors Total
N* Male Female Total N* Male Female Total
VIH (%) 47 0 (0.0) 0 (0.0) 0 (0.0) 406 7 (87.5) 1 (12.5) 8 (1.9) 8 (1.8)
VHB (%) 48 1 (100.0) 0 (0.0) 1 (2.1) 413 13 (86.7) 2 (13.3) 15 (3.6) 16 (3.5)
VHC (%) 47 1 (50.0) 1 (50.0) 2 (4.3) 396 4 (100.0) 0 (0.0) 4 (1.0) 6 (1.3)
T. Pallidum (%) 47 1 (100.0) 0 (0.0) 1 (2.1) 383 29 (85.3) 5(14.7) 34 (8.9) 35 (8.1)
Data are frequency (%) of various infections according to donors' groups and gender; *, Total number of donors where the diagnostic test was interpreted.
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prior to the current visit was 26 (31.3%) (Table 3). In the
Pediatric ward, 7 (58.3%) of the 12 recipients who had re-
ceived at least one previous blood transfusion were girls.
In the emergency ward, the 2 recipients who had received
at least one previous blood transfusion were men.
Transfusion indications
All recipients in the study were transfused for severe
anemia. The causes of anemia varied from one ward to
the other. In the Gyneco-obstetrical ward, the main
causes of anemia were hemorrhagic (postpartum hae-
morrhage, caesarean section due to placenta previa,
cervical damage, or voluntary abortions) and/or due to
urinary tract infections. In the Pediatric ward, anemia
was mostly due to malaria (severe malaria and recurrent
malaria). Hemolytic causes such as vaso-occlusive crises
were the leading cause of transfusion in sickle cell pa-
tients in the Pediatric ward. In the Emergency ward, se-
vere hemorrhagic anemia was noted in one patient with
knife injuries and another with a digestive haemorrhage.
Complications recorded
From clinical records of transfused patients, we reported
10 different transfusionnal complications (Table 4). Over-
all, 26 (31.3%) recipients presented with transfusion-
related complications. Among these, chills and hematuria
accounted for 46.1% (12/26), the majority (57.7%) of
which were recorded in the Gyneco-obstetrical ward.




Male (%) 0 (0.0)
Female (%) 43 (100.0)
Mean age (SD), years 29.1 (7.8)
Mean haemoglobin$ (SD), g/dL 5.6 (1.9)
Mean duration of transfusion (SD), min 191.9 (104.9)
Previous blood transfusion (%) 12 (27.9)
Data are frequencies (%) or mean (SD) according to wards; $Information on 47 indiv
Emergency wards).recorded at the Pediatrics and Emergency wards, respec-
tively. A significant trend was observed between multiple
transfusions and occurrence of complications (p = 0.05).
Three deaths were recorded during the study. The first pa-
tient was a 27 years old male with sickle cell disease; he
died two days after the transfusion and had previously re-
ceived one blood transfusion. His clinical record indicated
severe anemia (hemoglobin level 3.8 g/dl), and joints and
lumbar pains. The second was a 2 years old female who
died seven days after admission. Her clinical record in-
dicated severe anemia, palour, hematuria, nausea and
vomiting. She died following a sudden cardiac arrest be-
fore receiving the second blood unit following a shortage
of blood group O in the hospital blood bank. The third
patient, a girl under one year old, died two days after
transfusion. Her clinical record also indicated anemia
(hemoglobin level = 10.3 g/dl) and hyperthermia.
Discussion
In this study, we recorded 477 blood donors and 83 reci-
pients. Volunteer donors accounted for 10.5% and family
donors for 89.5%. There was statistically significant dif-
ference in blood donation between volunteer donors and
family donors (p = 0.03). We noticed a higher proportion
of volunteer donors compared to family donors attending
the LHD blood center. The reasons for increased vo-
luntary donation within the study population can be ex-
plained by various factors, including previous loss of a
relative due to lack of blood, or the quest for their HIV
status. Family donors are those who donate blood tos
Pediatric Emergency Total
(N = 36) (N = 4) (N = 83)
16 (44.4) 2 (50.0) 18 (21.7)
20 (55.6) 2 (50.0) 65 (78.3)
6.8 (8.7) 53.2 (24.5) 20.6 (16.1)
6.5 (3.4) 2.8 6.0 (2.9)
254.6 (167.7) 200.0 (24.5) 220.2 (137.1)
12 (33.3) 2 (50.0) 26 (31.3)
iduals (19, 27 and 1 respectively in Gyneco-obstetrical, Pediatric and
Figure 3 Distribution of blood recipients according to age classes.
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results are similar to those reported in other studies con-
ducted in several countries [7,18]. Contrarily to our study,
some studies conducted over long periods in France and
Turkey have shown that blood supply is mainly based on
volunteer donation [6,19]. With the presidential decree
signed on the 5th April 2013, recognizing the utility of the
“National Organization of volunteer blood donors, we can
expect in the near future that voluntary blood donation
becomes more frequent in Cameroon.
We reported a statistically significant difference be-
tween mean ages in the two donor groups (p = 0.017),
with volunteer donors dominating the older age group.






(N = 43) (N = 36) (N = 4) (N = 83)
Nausea 1 (2.3) 2 (5.6) 0 (0.0) 3 (3.6)
Vomiting 0 (0.0) 2 (5.6) 0 (0.0) 2 (2.4)
Chills 4 (9.3) 2 (5.6) 0 (0.0) 6 (7.2)
Hematuria 3 (6.9) 3 (8.3) 0 (0.0) 6 (7.2)
Anxiety 1 (2.3) 0 (0.0) 0 (0.0) 1 (1.20)
Anaphylaxis 1 (2.3) 0 (0.0) 1 (25.0) 2 (2.4)
Tachycardia 1 (2.3) 0 (0.0) 0 (0.0) 1 (1.2)
Icteria 2 (4.6) 0 (0.0) 0 (0.0) 2 (2.4)
Sudden diarrhea 2 (4.6) 0 (0.0) 0 (0.0) 2 (2.4)
Hyperthermia 0 (0.0) 0 (0.0) 1 (25.0) 1 (1.2)
Total 15 (34.9) 9 (25.0) 2 (50.0) 26 (31.3)
Data are frequencies (%) of transfusion complications recorded in each wards.33 years old group, which is consistent with a study con-
ducted in 2010 at the LHD [20]. This number decreased
considerably with age and volunteer donors represented
the majority of donors. We can hypothesize that many
persons of more than 30 years old and probably having
professional activities, voluntarily make blood donation,
unlike young people who may be forced to make blood
donation for family reasons.
Most donors had a secondary-school education, consis-
tent with a similar study in Côte d'Ivoire [21]. Male/female
sex ratio was 4/1 for all donors in our study. It was 2.8/1
from voluntary donors and 4.1/1 from family donors. In
2010, Dikosso [20] also found a higher frequency of men
among both donors groups; male/female sex ratio of 8/1
for family donors and 2/1 for volunteer donors at the
HLD. Our findings are consistent with previous obser-
vations in Cameroon [7,20,22], Tanzania [18], and in a
multicenter study involving seven sub-Saharan African
countries [18] that showed less representation of women
(< 30%) as blood donors, whether volunteer or not. This
could be explained by physiological differences between
men and women, who are not allowed to make blood do-
nation during menstruation, lactation or in pregnancy.
In our donor population, men are more infected than
women, but this difference was not significant. This trend
has also been reported in Cameroon [20] and in Côte
d’Ivoire [21]. HIV seroprevalence among blood donors
was 1.77%. This prevalence is lower than that found in
other localities of Cameroon (Edéa, Douala or Yaoundé)
with prevalences between 4.1% and 7.9% [20,23,24]. This
prevalence is also lower than the estimated national HIV
prevalence of 2.6% among blood donors in 2011 [25]. The
same year, the overall HIV seroprevalence in Cameroon
was estimated to be 4.3% and 4.6% in the coastal region
[26]. In our study, HIV infection was found only in 8/406
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observed in this study could be explained by the relatively
short recruitment period of 4 months compare to
> 6 months in others studies. Additionally, this could re-
sult from a change in people's attitudes following the ef-
forts of the National Committee for AIDS Control to
prevent HIV transmission. Another parameter that could
explain this difference is our sample size that is lower than
in similar studies. HIV prevalence in our study and in all
studies conducted in blood donors from 2003 was higher
than that found (0.4%) in Yaoundé in the 1990 [22]. This
could be explained by the introduction of 4th generation
tests that are more sensitive [8].
HBV infection was found in 3.5% of the donor popula-
tion. It was 2.1% (1/48) among volunteer donors and 3.7%
(15/413) among family donors. These prevalence values
are lower than the prevalence reported in Cameroon in
2003, 2004, and 2012, that were 10.7%, 9.9% and 10.1%,
respectively [23,24,27].
HCV seroprevalence in our donor population was
1.35%. It was 4.2% (2/47) among volunteer donors and
1.0% (4/396) among family donors. The overall prevalence
was lower than that reported (2.3%) in 2003 by Koanga
et al. [7] in the LHD, but identical to the 1.6% prevalence
reported in Tanzania in 2006 by Mecky et al. [18]. This
difference could result from differences in the used diag-
nostic tests. In the study conductyed by Mogtomo, HCV
diagnosis was performed only by ELISA, whereas a com-
bination of RDT and ELISA were employed in our studies.
National HCV seroprevalence was estimated to 13.8% in
2002, with regional variations [28].
The prevalence of T. Pallidum infection is high in our
study. The prevalence in volunteer donors was 2.1% while
it was 8.88% among family donors. The overall seropreva-
lence among all donors was 8.1%, similar to the 2003
prevalence of 7.9% in the same hospital [7]. It was higher
than the 5.7% reported in the regional hospital of Edea in
2012 [23], and lower than the 9.1% found at the University
Teaching Hospital of Yaoundé in 2003 [24]. In other stu-
dies conducted in Cameroon and elsewhere [12,13], high
prevalence of T. pallidum infection have been reported.
Syphilis seems to be overlooked in Cameroon and there is
no awareness campaign for this infection. Most are
unaware of their T. pallidum status until probably at the
moment of blood donation when the infection is diag-
nosed. Another problem is the absence of serological re-
sults given to family donors in LHD. This suggests that
family donors with positive T. pallidum test do not know
their status and could therefore continue to serve as reser-
voirs for the bacteria, which can lead to infertility. Taken
together, these findings indicate that bacterial contamin-
ation is the major risk of infection during blood transfu-
sion. In addition, we report a single case of co-infection
HCV/T. pallidum in the study population. In a studyconducted in China, HIV/T. pallidum and HBV/T. palli-
dum co-infections were noticed in addition to HCV/T.
pallidum infected cases [13]. The prevalence of T. palli-
dum infections and co-infections was probably underesti-
mated in our study given that the HIV positive
participants were not screened for T. pallidum infection.
None of the assessed risk factors was significantly asso-
ciated with infection in our study. This is consistent with
the study conducted in Australia between 2005 and 2010
in a population of infected blood donors [5]. However,
Kra et al., in 2001 had found that having multiple part-
ners, unprotected sex, or history of hazardous behavior
(injections, blood transfusions) were risk factors for posi-
tive HBsAg among blood donors in Côte d'Ivoire [21].
We recorded 83 blood recipients (male/female sex ratio
of 3.6/1) in the Pediatric, Gyneco-obstetrical and emer-
gency wards. These wards were chosen because they pre-
sented the highest blood requests as noted in blood bank
records. The high number of female recipient is due to
the high frequency of anemia in Gyneco-obstetrical ward.
Various complications have been identified from medical
records of patients during and after transfusion, and
31.32% of recipients had at least one complication. This
value is lower than that obtained by Mbanya et al. (> 50%)
between 1994 and 1998 in Cameroon [11]. Complications
were mainly found in Gyneco-obstetrical ward, as well as
the number of blood transfusions. This could be explained
by frequent bleeding in women during childbirth. Studies
have shown that transfusion occurs when blood loss
exceeds 500 ml [29,30]. Chills and hematuria were the
most frequent complications (14.5% of recipients) and
accounted for 46.1% of all complications. Mbanya et al.
reported febrile reactions and urticaria in 40.1% and 19.4%
recipients respectively [11]. Chills and hematuria are signs
and symptoms of acute or delayed hemolytic reactions.
Chills may be due to the fact that some transfused patients
did not receive blood of the same group. Due to lack of
blood, several patients received O group blood although
not belonging to this group. The O group was predomi-
nant among all blood donors in our study (52.2%), and
blood transfusion in this group was generally for emer-
gency purposes. A study conducted by Mandengue et al.
(2003) in the LHD showed the existence of several blood
systems and also, that the distribution among donors and
recipients is not always the same [31]. Hematuria due to
non-immune hemolysis of red blood cells compatibility
was particularly observed in Sickle Cell Disease (SCD) in
our study. Among the recipients, 10 SCD patients agreed
to participate in this study. SCD patients are generally
subject to blood transfusions. A study conducted in
Yaoundé in 2012 by Ngo Sack et al. showed that SCD pa-
tients may receive more than 10 transfusions and that the
risk of infection increases with the number of transfusion
[32]. Another study conducted in Libreville in 2002 by
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used in systematic prophylaxis [33].
Among the recipients, 57 (68.7%) were transfused for
the first time and 26 (31.3%) had received previous
transfusions. The number of previous transfusion was
higher in Gyneco-obstetrical and Pediatric wards. In
the Pediatric ward, anemia due to malaria was the
main indication for transfusion, followed by sickle cell
vaso-occlusive crisis. In a study conducted in Benin,
malarial anemia was the main indication for blood
transfusion in Pediatric wards, followed by malnutri-
tion, viral and bacterial infections (pneumonia, menin-
gitis, measles, typhoid fever), and SCD [34]. Our
results, however, do not reflect the morbidity associ-
ated with sickle cell disease.Limitations and strengths
The weaknesses of this study include: 1) the small sample
size (83 recipients) and the lack of funding which limited
our ability to explore seroconversion of viral and bacterial
infections in blood recipients and 2) the low representa-
tion of all sub-regional hospitals in this study that poten-
tially could impose significant bias in the obtained data;
for instance, if a patient visited another hospital with an
acute complication, our institution database may not have
a record of that visit.
Compared to previous reports in this area, our study is
one of the few researches to investigate transfusion-related
complications in blood recipients attending the HLD,
while past research has largely focused on blood donors.
This study provides a comprehensive analysis of the preva-
lence of both viral and bacterial infections among blood
donors in Douala, providing additional insight into TTI-
associated disease burdens and opportunities for preven-
tion from a local standpoint.Conclusion
The aim of this study was to investigate the prevalence of
TTIs among blood donors, and complications due to
transfusion in blood recipients attending the LHD. HIV,
HBV, HCV and T. pallidum infections in blood donors
were recorded with a high proportion of T. pallidum in-
fection, representing over 53.84% of all infections. Infec-
tion prevalences were two folds higher in family donors
than in volunteer donors, suggesting a low-risk in this
later group. We also reported hematuria in the majority of
complications found in blood recipients. However, studies
on malaria infection and on seroconversion rate of viral or
bacterial infections in blood recipients are also required.
Taken together, our findings will contribute to significantly
to ongoing efforts to improve transfusion-related haemo-
vigilance in blood recipients at the HLD and the sub-
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